Establishment Labs Corp (ESTA) Narxning foydaga nisbati
Establishment Labs (ESTA) o'sishi AQSh bozoridagi kengayish va yuqori mahsulot marjalariga bog'liq. GURU.Markets grafigidagi kompaniyaning 12 oylik P/E (TTM) dinamikasi bozor bahosini aniq ko'rsatadi, bunda -54.10 parametrning joriy holatini belgilaydi. Kosta-Rikadagi ishlab chiqarish korxonalari global taqsimotni ta'minlaydi. Kuchli patent portfeli va 80 ta mamlakatdagi sertifikatsiya raqobatchilar uchun ishonchli kirish to'sig'ini yaratadi.
Motiva (ESTA) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi tafsilotlari:
- balans kapitallashuvi haqida ma'lumot:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Qarzning kapitalga nisbati Establishment Labs|ESTA - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi Establishment Labs Inc|ESTA - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Establishment Labs Holdings Inc.|ESTA - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli majburiyatlari Establishment Labs|Shoshilinch likvidlik establishmentlabs.com
- foyda va bozor multiplikatorlari tafsilotlari:
ESTA - Sof foyda|Sof foyda prognozi Establishment Labs|ESTA - P/E multiplikatori|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Establishment Labs Corp|ESTA - PEG multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti Establishment Labs Holdings Inc.|ESTA - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) Establishment Labs|ESTA - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi establishmentlabs.com|ESTA - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi Establishment Labs
Kompaniyaning umumiy tahlili:establishmentlabs.com - ESTA
P/E koeffitsienti foydaning bitta birligining bozor qiymatini aks ettiradi, bu esa investorga joriy aksiya narxini biznesning fundamental daromadlari bilan solishtirish orqali investitsiyalarning qoplanish muddatini aniqlash imkonini beradi. Establishment Labs (ESTA) uchun o'rtacha P/E tahlili kompaniyaning premium implantlar segmentidagi texnologik ustunligi uning yuqori bozor bahosini oqlashini tasdiqlaydi va estetik tibbiyot sohasiga kengayishi fonida kapitalning uzoq muddatli o'sish potentsialini ta'minlaydi.
Raqobatdosh kompaniyalar tahlili
P/E multiplikatori bostonscientific.com|Narxning foydaga nisbati Edwards Lifesciences Corporation (EW)|Narxning foydaga nisbati RMD (ResMed Inc)|P/E multiplikatori PODD (OmniPod)|Biznesning o‘zini qoplash muddati Zimmer Biomet (ZBH)|COO: Narx-foyda koeffitsiyenti|Kapitalizatsiyaning sof foydaga nisbati ALGN|GMED: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati TransMedics Organ Care System (TMDX)|ATEC (ATEC Spine) - P/E multiplikatori|Narx-foyda multiplikatori AORT (Artivion Corp)|Narx-foyda koeffitsiyenti ENOV (Enovis Corporation)|IART (integralife.com) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Beta Bionics BBNX|IRMD - Narx-foyda koeffitsiyenti|Embecta Inc. - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Tandem Corp|AXGN: P/E multiplikatori|Narx-foyda multiplikatori SIBN|OFIX (Orthofix) - P/E multiplikatori|Bioventus Inc (BVS) - Biznesning o‘zini qoplash muddati|P/E multiplikatori KIDS|Narx-foyda koeffitsiyenti Treace Corp TMCI|P/E multiplikatori SRTA (Strata Critical Medical Inc)|P/E multiplikatori carlsmed.com CARL|RXST - Narxning foydaga nisbati|CLPT: Narxning foydaga nisbati|STXS (Stereotaxis Corp) - Narx-foyda koeffitsiyenti|Neuronetics, Inc - Kompaniya qiymatining sof foydaga nisbati|SGHT (Sight Sciences, Inc.) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati orchestrabiomed.com OBIO|Narxning foydaga nisbati Anika Therapeutics (ANIK)|InspireMD Inc (NSPR) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Jin Medical - Narx-foyda koeffitsiyenti|P/E multiplikatori Vivani Medical Inc VANI|Xtant Medical Inc - P/E multiplikatori|Biznesning o‘zini qoplash muddati n1mtc.com NMTC|modular-medical.com (MODD) - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati MYO (Myomo Inc.)|Narxning foydaga nisbati Envoy Medical, Inc|Narx-foyda koeffitsiyenti Vivos Therapeutics Inc (VVOS)|P/E multiplikatori NVNO|SINT - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Tenon Medical TNON|LFWD: Narx-foyda multiplikatori|AMIX: Narx-foyda koeffitsiyenti|INVO Fertility Corp - Bozor narxining sof foydaga nisbati|BBLG: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati axonics.com (AXNX)|Narxning foydaga nisbati BIOLASE|Dynatronics Corp. (DYNT) - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti FNA (Paragon 28, Inc.)|Bozor narxining sof foydaga nisbati INVO
